{"id":5350,"date":"2022-10-28T12:48:50","date_gmt":"2022-10-28T12:48:50","guid":{"rendered":"https:\/\/preprod.treefrog.fr\/?p=5350"},"modified":"2022-11-02T10:48:16","modified_gmt":"2022-11-02T10:48:16","slug":"new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo","status":"publish","type":"post","link":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/","title":{"rendered":"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"5350\" class=\"elementor elementor-5350\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-700a500 elementor-section-boxed elementor-section-height-default elementor-section-height-default parallax_section_no qode_elementor_container_no\" data-id=\"700a500\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a9b0a84\" data-id=\"a9b0a84\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6bb9c05 elementor-widget elementor-widget-video\" data-id=\"6bb9c05\" data-element_type=\"widget\" data-settings=\"{&quot;youtube_url&quot;:&quot;https:\\\/\\\/youtu.be\\\/7WxHnvF9wMc&quot;,&quot;video_type&quot;:&quot;youtube&quot;,&quot;controls&quot;:&quot;yes&quot;}\" data-widget_type=\"video.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-wrapper elementor-open-inline\">\n\t\t\t<div class=\"elementor-video\"><\/div>\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1548679 elementor-widget elementor-widget-text-editor\" data-id=\"1548679\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span lang=\"EN-US\">&#8220;This GMP encapsulation device is our ticket to the clinic&#8221; Michael Lanero Fidalgo, Chief Operating Officer at TreeFrog Therapeutics, comes back on the newly delivered GMP-grade C-Stem\u2122 platform (read full Press Release <a href=\"https:\/\/preprod.treefrog.fr\/treefrog-therapeutics-moves-to-gmp-manufacturing-with-cell-encapsulation-device-delivered-by-invetech\/\">here<\/a>).<\/span><\/p><p><strong><span lang=\"EN-US\">Key features :<\/span><\/strong><\/p><p><span lang=\"EN-US\">&#8211; High-throughput cell encapsulation : &gt;1,000 capsules per second (capsules are engineered to provide cells with a biomimetic microenvironment protected from external stress).<br \/><\/span><\/p><p><span lang=\"EN-US\">&#8211; Suited to seed bioreactors from 200mL to 10L for :<br \/>#1 Large-scale stem cell expansion (&gt;250x\/week iPSC amplification with best-in-class cell quality)<br \/>#2 Stem cell differentiation into ready-to-graft 3D microtissues<\/span><\/p><p><span lang=\"EN-US\">&#8211; Easy capsule dissolution in minutes to release cellular content<\/span><\/p><p><span lang=\"EN-US\"><strong>Next steps:<br \/><\/strong><br \/>&#8211; 2023 : transfer to CDMO to manufacture clinical-grade batches of TreeFrog\u2019s cell therapy program in Parkinson\u2019s disease<\/span><\/p><p><span lang=\"EN-US\">&#8211; 2023: 3 additional GMP encapsulation devices delivered to support TreeFrog\u2019s cell therapy pipeline in regenerative medicine and immune-oncology<\/span><\/p><p><span lang=\"EN-US\">&#8211; 2024 : IND followed by first-in-human trials in Parkinson\u2019s disease<\/span><\/p><p>Congrats to the froggies and our partners in automation, Invetech.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja\/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR\u2122 technology and her interest in TreeFrog&#8217;s C-Stem\u2122 platform for the development of iPSC-derived allogeneic products in immuno-oncology.<\/p>\n","protected":false},"author":1,"featured_media":5352,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[12,13,15],"tags":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"og:description\" content=\"We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja\/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR\u2122 technology and her interest in TreeFrog&#039;s C-Stem\u2122 platform for the development of iPSC-derived allogeneic products in immuno-oncology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/\" \/>\n<meta property=\"og:site_name\" content=\"TreeFrog Therapeutics I iPS-derived cell therapies\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-28T12:48:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-02T10:48:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2022\/10\/thumbnail-mlf-yt.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1335\" \/>\n\t<meta property=\"og:image:height\" content=\"750\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Piergueritona\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/\",\"url\":\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/\",\"name\":\"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies\",\"isPartOf\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\"},\"datePublished\":\"2022-10-28T12:48:50+00:00\",\"dateModified\":\"2022-11-02T10:48:16+00:00\",\"author\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\"},\"breadcrumb\":{\"@id\":\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/preprod.treefrog.fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#website\",\"url\":\"https:\/\/preprod.treefrog.fr\/\",\"name\":\"TreeFrog Therapeutics I iPS-derived cell therapies\",\"description\":\"Cell Therapy for All\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/preprod.treefrog.fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220\",\"name\":\"Piergueritona\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g\",\"caption\":\"Piergueritona\"},\"sameAs\":[\"https:\/\/preprod.treefrog.fr\"],\"url\":\"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies","og_description":"We had the chance to interview Teisha Rowland, Ph.D., Principal Scientist at Umoja Biopharma during the ISSCR in San Francisco about the Umoja\/TreeFrog partnership. Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR\u2122 technology and her interest in TreeFrog's C-Stem\u2122 platform for the development of iPSC-derived allogeneic products in immuno-oncology.","og_url":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/","og_site_name":"TreeFrog Therapeutics I iPS-derived cell therapies","article_published_time":"2022-10-28T12:48:50+00:00","article_modified_time":"2022-11-02T10:48:16+00:00","og_image":[{"width":1335,"height":750,"url":"https:\/\/preprod.treefrog.fr\/wp-content\/uploads\/2022\/10\/thumbnail-mlf-yt.jpg","type":"image\/jpeg"}],"author":"Piergueritona","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/","url":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/","name":"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo - TreeFrog Therapeutics I iPS-derived cell therapies","isPartOf":{"@id":"https:\/\/preprod.treefrog.fr\/#website"},"datePublished":"2022-10-28T12:48:50+00:00","dateModified":"2022-11-02T10:48:16+00:00","author":{"@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220"},"breadcrumb":{"@id":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/preprod.treefrog.fr\/new-gmp-cell-encapsulation-device-interview-of-coo-michael-lanero-fidalgo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/preprod.treefrog.fr\/"},{"@type":"ListItem","position":2,"name":"New GMP cell encapsulation device : interview of COO Michael Lanero Fidalgo"}]},{"@type":"WebSite","@id":"https:\/\/preprod.treefrog.fr\/#website","url":"https:\/\/preprod.treefrog.fr\/","name":"TreeFrog Therapeutics I iPS-derived cell therapies","description":"Cell Therapy for All","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/preprod.treefrog.fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/ab868aec652cf07c221b48c1dc91a220","name":"Piergueritona","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/preprod.treefrog.fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5270054e7ba7a649b1bc59c924e224e1?s=96&d=mm&r=g","caption":"Piergueritona"},"sameAs":["https:\/\/preprod.treefrog.fr"],"url":"https:\/\/preprod.treefrog.fr\/author\/piergueritona\/"}]}},"_links":{"self":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/5350"}],"collection":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/comments?post=5350"}],"version-history":[{"count":15,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/5350\/revisions"}],"predecessor-version":[{"id":5373,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/posts\/5350\/revisions\/5373"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media\/5352"}],"wp:attachment":[{"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/media?parent=5350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/categories?post=5350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/preprod.treefrog.fr\/wp-json\/wp\/v2\/tags?post=5350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}